J. Nita Cogburn

Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors:  Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1<i>H</i>-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)

Thomas D. Penning, John J. Talley, Stephen R. Bertenshaw et al. · Journal of Medicinal Chemistry · 1997 · 1.9K citations · Full text

1,2-Diarylcyclopentenes as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents

James J. Li, Gary D. Anderson, Earl G. Burton et al. · Journal of Medicinal Chemistry · 1995 · 177 citations · Full text

Pharmaceutical Science, Chemoprevention Strategy, Pharmacotherapy +16

Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats

Susan K. Paulson, Ji Y. Zhang, Alan P. Breau et al. · Drug Metabolism and Disposition · 2000 · 130 citations

Selective Cyclooxygenase-2 Inhibitors:  Heteroaryl Modified 1,2-Diarylimidazoles Are Potent, Orally Active Antiinflammatory Agents

Ish Khanna, Yi Yu, Renee M. Huff et al. · Journal of Medicinal Chemistry · 2000 · 111 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Selective Cyclooxygenase-2 Inhibitors +17

A Model of Human Small Intestinal Absorptive Cells. 1. Transport Barrier

J. Nita Cogburn, Matthew Donovan, Charles S. Schasteen · Pharmaceutical Research · 1991 · 110 citations